Stablepharma Ltd. has initiated a Phase 1 clinical trial for its lead candidate, SPVX02, a fridge-free tetanus and diphtheria...

Foghorn Therapeutics announced preclinical data for several potential first-in-class cancer medicines, including FHD-909, a SMARCA2 inhibitor, and its selective...

Tenaya Therapeutics announced interim data from its RIDGE natural history study of adults with arrhythmogenic right ventricular cardiomyopathy (ARVC)...

Verana Health launched Qdata® Cataracts, a comprehensive dataset on cataract surgery outcomes derived from over 9 million de-identified patients...

Inmagene Biopharmaceuticals announced positive topline results from a Phase 2a trial of IMG-007, a non-depleting anti-OX40 monoclonal antibody, in...

Northstrive Biosciences, a subsidiary of PMGC Holdings, received positive feedback from the FDA regarding its pre-IND meeting request for...

SpyGlass Pharma announced positive 18-month data from its first-in-human study of a novel drug delivery platform for glaucoma and...

Bioxodes SA announced positive interim results from its Phase 2a BIRCH trial of BIOX-101 for intracerebral hemorrhagic stroke (ICH)....

Mineralys Therapeutics announced positive Phase 2 Advance-HTN trial results for lorundrostat, a novel treatment for uncontrolled or resistant hypertension...

The Oncology Institute (TOI) is expanding its partnership with Helios Clinical Research to bring clinical trials to more community...